http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100856363-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06 |
| filingDate | 2005-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100856363-B1 |
| titleOfInvention | Quinoline thiazolinone with CDD1 antiproliferative activity |
| abstract | The present invention provides the following novel thiazolinone disubstituted quinoline derivatives having a quinoline ring substituted at positions 3 and 4, which are useful as anticancer agents because they exhibit CDK1 antiproliferative activity:n n n . |
| priorityDate | 2004-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 838.